Identification of EphB6 variant-derived epitope peptides recognized by cytotoxic T-lymphocytes from HLA-A24+ malignant glioma patients

Oncology Reports

Volumn 19, Issue 5, 2008, Pages 1277-1283

  Jin, Mingyue ^a,b   Komohara, Yoshihiro ^a   Shichijo, Shigeki ^a,c   Harada, Mamoru ^a,c   Yamanaka, Ryuya ^a   Miyamoto, Shigeaki ^b   Nikawa, Junichi ^b   Itoh, Kyogo ^a,c   Yamada, Akira ^a  

^a KURUME UNIVERSITY   (Japan)

^b KYUSHU INSTITUTE OF TECHNOLOGY   (Japan)

^c KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cytotoxic T lymphocytes; EphB6; Glioma; HLA A24; Peptide

Indexed keywords

EPHRIN RECEPTOR B6; HLA A24 ANTIGEN; COMPLEMENTARY DNA; EPITOPE; HLA A ANTIGEN; PEPTIDE;

AMINO ACID SEQUENCE; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BIOSYNTHESIS; BRAIN TUMOR; CHEMISTRY; GENE EXPRESSION REGULATION; GLIOMA; IMMUNOLOGY; IMMUNOTHERAPY; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; PATHOLOGY; TUMOR CELL LINE;

AMINO ACID SEQUENCE; BRAIN NEOPLASMS; CELL LINE, TUMOR; DNA, COMPLEMENTARY; EPITOPES; GENE EXPRESSION REGULATION; GLIOMA; HLA-A ANTIGENS; HUMANS; IMMUNOTHERAPY; MOLECULAR SEQUENCE DATA; PEPTIDES; RECEPTOR, EPHB6; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, CYTOTOXIC;

EID: 47549091383     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.19.5.1277     Document Type: Article

References (19)

1. Stupp R, Mason WP, Weller M, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996, 2005.
2. Yamanaka R: Novel immunotherapeutic approaches to glioma. Curr Opin Mol Ther 8: 46-51, 2006.
3. Rosenberg SA, Yang JC and Restifo NP: Cancer immunotherapy: moving beyond current vaccines. Nat Med 10: 909-915, 2004.
4. Itoh K and Yamada A: Personalized peptide vaccines: a new therapeutic modality for cancer. Cancer Sci 97: 970-976, 2006.
5. Srivastava PK: Therapeutic cancer vaccines. Curr Opin Immunol 18: 201-205, 2006.
6. Lewis JJ: Therapeutic cancer vaccines: using unique antigens. Proc Natl Acad Sci USA 101: 14653-14656, 2004.
7. Matsuoka H, Iwata N, Ito M, Shimoyama M, Nagata A, Chihara K, Takai S and Matsui T: Expression of a kinase-defective Eph-like receptor in the normal human brain. Biochem Biophys Res Commun 235: 487-492, 1997.
8. Gurniak CB and Berg LJ: A new member of the Eph family of receptors that lacks protein tyrosine kinase activity. Oncogene 13: 777-786, 1996.
9. Shimoyama M, Matsuoka H, Tamekane A, Ito M, Iwata N, Inoue R, Chihara K and Furuya A: T-cell-specific expression of kinase-defective Eph-family receptor protein, EphB6 in normal as well as transformed hematopoietic cells. Growth Factors 18: 63-78, 2000.
10. Nakao M, Shichijo S, Imaizumi T, Inoue Y, Matsunaga K, Yamada A, Kikuchi M, Tsuda N, Ohta k, Takamori S, Yamana H, Fujita H and Itoh K: Identification of a gene coding for a new squamous cell carcinoma antigen recognized by the CTL. J Immunol 164: 2565-2574, 2000.
11. Takiguchi M, Matsuda T and Tomiyama H: Polarity of the P1 anchor residue determines peptide binding specificity between HLA-A*3101 and HLA-A*3303. Tissue Antigens 56: 501-506, 2000.
12. Komatsu N, Shichijo S, Nakagawa M and Itoh K: New multiplexed flow cytometric assay to measure anti-peptide antibody: a novel tool for monitoring immune responses to peptides used for immunization. Scand J Clin Lab Invest 64: 535-546, 2004.
13. Hida N, Maeda Y, Katagiri K, Takasu H, Harada M and Itoh K: A simple culture protocol to detect peptide-specific cytotoxic T lymphocyte precursors in the circulation. Cancer Immunol Immunother 51: 219-228, 2002.
14. Mine T, Sato Y, Yamada A, Todo S, et al: Humoral responses to peptides correlate with overall survival in advanced cancer patients vaccinated with peptides based on pre-existing, peptide-specific cellular responses. Clin Cancer Res 10: 929-937, 2004.
15. Eph nomenclature committee: Unified nomenclature for Eph family receptors and their ligands, the ephrins. Cell 90: 403-404, 1997.
16. Tang XX, Brodeur GM, Campling BG and Ikegaki N: Coexpression of transcripts encoding EPHB receptor protein tyrosine kinases and their ephrin-B ligands in human small cell lung carcinoma. Clin Cancer Res 5: 455-460, 1999.
17. Tang XX, Evans AE, Zhao H, et al: High-level expression of EPH136, EFNB2, and EFNB3 is associated with low tumor stage and high TrkA expression in human neuroblastomas. Clin Cancer Res 5: 1491-1496, 1999.
18. Tang XX, Zhao H, Robinson ME, Cohen B, Cnaan A and London W: Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma. Proc Natl Acad Sci USA 97: 10936-10941, 2000.
19. Hafner C, Bataille F, Meyer S, Becker B, Roesch A, Landthaler M and Vogt T: Loss of EphB6 expression in metastatic melanoma. Int J Oncol 23: 1553-1559, 2003.